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Genetic aspects of diabetic nephropathy. 40% for diabetic nephropathy after 25 years of diabetes.
Background. Diabetic nephropathy from type 2 diabetes This enormous variance is based on the fact that type 2
mellitus is the most common cause of end-stage renal disease diabetes can remain undiagnosed for a long time,(ESRD) in the United States and in Western Europe. Although
whereas type 1 diabetes leads to clinical attention withpatients with overt nephropathy generally experience greater
the initiation of disease.cumulative glycemic exposure, the difference in glycemic con-
trol between patients developing nephropathy compared to The prevalence of diabetic nephropathy depends on
those who did not, could not be demonstrated. This observation ethnic background. Pima, Navajo, Winnebago, and Omaha
is consistent with the notion that perhaps other factors, in Indians show the highest prevalence [5]. Caucasians ofaddition to glycemic control, have a bearing on the develop-
European origin demonstrate the lowest prevalence [6].ment of nephropathy. Genetic factors, which specifically in-
The prevalence of diabetic nephropathy in type 2 diabe-crease the susceptibility to nephropathy in patients with diabe-
tes, have been proposed. tes in African Americans is four times higher when com-
Methods. A range of linkage and association studies has pared with a population on non-Hispanic whites [7, 8].
been performed for revealing the genetic background of dia-
This relation is reversed in type 1 diabetes.betic nephropathy.
Results. Until now, no mutation has been identified which
could explain the development of diabetic nephropathy in the
GENETIC AND NONGENETIC FACTORSmajority of diabetic patients.
Conclusions. Because of relatively small case numbers of The pathogenesis of type 2 diabetes and diabetic ne-
all studies being performed so far, conclusions from those stud- phropathy is promoted by an individual genetic predis-ies are limited. With the development of better technologies
position (mono- and polygenic factors), which is influ-for an affordable genome-wide association study using thou-
enced by environmental factors (physical activity, diet,sands of markers, it might become possible to unravel the
genetic causes of diabetic nephropathy. overweight, climate, metabolic control) in its phenotypic
expression. For about 10 years, diseases like diabetes
mellitus or coronary heart disease, which follow this pat-
tern, have been called complex diseases.
Why is it that diabetes and diabetic nephropathy canEPIDEMIOLOGY
be defined as inherited diseases? Pincus and White wrote
At least 90% of the 12 to 15 million persons with in 1933 that 10% to 30% of first-degree relatives of
diabetes mellitus in the United States have type 2 diabe-
diabetic patients have diabetes, whereas diabetes occurs
tes mellitus. In Western Europe, the figures are of a similar
only in 1% to 6% of first-degree relatives of nondiabeticmagnitude; a reasonable estimate in Germany is 5 to 8
subjects [9]. Similar studies followed, which all stronglymillion persons [1].
supported the thesis of genetic predisposition for type 2After 20 years of diabetes duration, 30% of all type 1
diabetes.diabetic patients develop diabetic nephropathy [3]. It is
For diabetes nephropathy, it was shown that metabolicremarkable that the later development of diabetic ne-
control did not differ in diabetic patients, both with andphropathy gets unlikelier after more than 20 years of
without nephropathy. A significant amount of diabetictype 1 diabetes without diabetic nephropathy. Under
patients did not develop diabetic nephropathy, despitegood metabolic control (average glycated or glycosylated
long-term severe chronic hyperglycemia [10]. The ge-haemoglobin A1c [HbA1c] of 7.2%), less than 10% of type 1
netic predisposition in type 1 and type 2 diabetic patientsdiabetic patients who became diabetic before the age of
with nephropathy could be proven by many studies in15 years reach the stadium of diabetic nephropathy [4].
different populations [4]. Some families with several dia-Type 2 diabetic patients show a prevalence of 25% to
betic patients presented almost no clinical signs of dia-
betic nephropathy, whereas 80% of diabetic patients
from other families developed diabetic nephropathy. 2003 by the International Society of Nephrology
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The high ethnic variance indicates geographic and diet- large pedigrees was intriguing. The prevalence of a se-
quence variant is simply compared between a case anddetermined factors; on the other hand, it reflects genetic
heterogeneity. Siblings of type 1 diabetic patients with a control group. Only single subjects are required. In prin-
ciple, a specific feature will be compared between families.diabetic nephropathy have a higher risk for developing
diabetic nephropathy [11, 12]. The rate of relatives of Candidate gene studies based on association have rarely
been successful. The entire literature contains very con-type 2 diabetic patients on dialysis developing ESRD is
five times higher (37%) than in relatives of type 2 dia- tradictive observations. The best known polymorphisms
are the angiotensin convertase insertion (I)/deletion (D)betic patients without nephropathy (7%; African Ameri-
cans) [13]. If both parents present with diabetic nephrop- polymorphism (DCP1), and the angiotensinogen poly-
morphism M235T [14–17]. Initial studies showed associa-athy the disease was observed in 46% of the offspring. In
contrast, only 23% of the offspring progressed to diabetic tion with diabetic nephropathy, but further studies failed
to replicate those results. The discrepancies could be ex-nephropathy if only one parent was proteinuric, and 14%
if both parents had no proteinuria (Pima Indians) [5]. plained by genetic heterogeneity by relatively small gene
effects in stratified populations with relatively small
numbers of cases (100 to 200). Most of the studies did
GENETIC STUDIES
not test functional effects of their associated variant.
General problems of genetic analyses of Furthermore, only significance levels of P  0.05 tested
complex diseases one sided have mostly been used. Table 1 gives a sum-
mary about conflicting results of some association studies.Phenotypically-oriented basic research did not lead to
a breakthrough in revealing the pathogenesis of diabetic Why those very different results? What can a positive
association implicate with regard to the disease? Proba-nephropathy. No mutations in genes have been identified
which would be able to cause diabetic nephropathy. bly not much. A positive association can occur if the
tested allele A causes the disease. In this case, it mustThe development of a high-resolution microsatellite
marker map with hundreds of markers at the beginning be possible to find the same association in all investigated
populations because the mutation triggers the diseaseof the 1990s, enabled larger genetic association and link-
age studies. Until that time, those studies were carried (assuming identical phenotypes without phenocopies).
A positive association can also occur if allele A does notout using only a few restriction fragment polymorphisms
(RFLP). The aim of genetic studies was, and is, to get cause the disease but is in linkage disequilibrium (LD)
with the “true” variant. Positive associations could alsoa genetic explanation and classification for the many
different clinical phenotypes. occur as an artifact of an admixed population. In an ad-
mixed population, every disease that occurs with theIn studying the pathogenesis of diabetes and nephrop-
athy genetically, a lot of seemingly unsolvable problems same prevalence in each of the population’s ethnic sub-
units could be positively associated with every allele thatcame up immediately. Because of the multifactorial patho-
genesis, no simple Mendelian inheritance model could be occurs at a higher frequency in the cases compared to
controls [18].administered, and because of the lower life expectancy
and the late age at diagnosis, parents of affected individu- To avoid false-positive associations, only relatively ho-
mogeneous populations should be investigated. Testingals are mostly dead. The heterogeneous clinical picture of
diabetes did not lead to a clear diagnosis. Neither bio- the Hardy-Weinberg equilibrium in the sample set is
essential for association studies. In some cases, that testchemically nor genetically may one identify subjects at
risk among the offspring. Children cannot deliver any in- would indicate the presence of subgroups with a different
ethnic background. For a correct analysis, those groupsformation about the at-risk status. Therefore, it was not
possible to perform traditional, logarithm of the odds (lod) must be analyzed separately. Serious association studies
must contain functional data. The control group mustscore-based pedigree analyses. Furthermore, there was a
good chance that diabetes runs in families not necessarily not contain potential at-risk subjects. Because of the
population size and, therefore, the amount of meioseswith nephropathy. Because of the lack of extended pedi-
grees with a clear inheritance pattern, scientists focused and crossing over, the responsible LD would extend over
such a short distance that thousands of markers must beon association studies and special approaches of linkage
analyses. screened in order to be successful with this particular
method. That is not an easy task, given the complexity
Association studies (case control studies) of most multifactorial diseases.
For a long time researchers have been concentrating
Linkage studies, genome scanson association studies with polymorphic markers right
next to candidate genes or variants within the coding se- Linkage studies are performed in two variants: (1)
Genome-wide scans of markers without a candidate genequence of the genes. The simplicity of such a study design
with single individuals without the necessity of collecting hypothesis (positional cloning); and (2) test of markers
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Table 1. Selected association studies on diabetic nephropathy with sequence variants within coding and noncoding sequences of candidate genes
Gene/region Symbol Type of diabetes Associated Not associated
Angiotensin-converting enzyme II/DD DCP1 T2DM [24] [25]
DCP1 T1DM [26]
Angiotensinogen AGT T2DM [27] [28]
AGT T1DM [17] [29]
Angiotensin-II-receptor-1 AGTR1 T2DM [30]
AGTR1 T1DM [31] [32]
Apolipoprotein E APOE T2DM [33]
APOE T1DM [34] [35]
Interleukin-1 receptor antagonist IL1RN T2DM [36]
IL1RN T1DM [36]
Atrial natriuretic peptide (ANP) ANP T2DM [37] [38]
ANP T1DM [37] [38]
Aldose reductase ALDR1 T2DM [39]
ALDR1 T1DM [40] [41]
Endothelial NO synthase ecNOS T2DM [42] [43]
ecNOS T1DM [44] [43]
3-Adrenergic receptor ADRB3 T2DM [45]
ADRB3 T1DM [46]
Matrix metal proteinase MMP9 T2DM [47]
Thrombocyte glycoprotein IIIa GPIIb-IIIa T2DM [48]
Type IV collagen COL4A1 T1DM [49]
Interleukin-1 IL1B T1DM [50]
Renin REN T1DM [51]
Pronatriodilatin PND T1DM [52]
Abbreviations are: T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.
for candidate genes. For an ideal linkage study extended of the six responsible genes for the different MODY
forms are parts of a transcription factor network (Fig. 1).pedigrees are required. Specific designs like the affected
sib pair approach have been developed because large MODY5 (HNF-1 gene) presents type 2 diabetes, to-
gether with chronic renal failure, and leads to dialysis.pedigrees have not been available for most “complex”
diseases. In principle, the focus is on the inheritance of Until now there are only six MODY5 families known.
The original MODY5 family from Japan presented dia-a specific trait within families.
Because of the late age at diagnosis, the significantly betes and a relatively early occurring renal failure. Both
traits were transmitted together with the mutation [19].increased mortality of patients with diabetic nephropa-
thy, and the missing inheritance model, it is not possible In another family from Norway, type 2 diabetes, renal
failure, and Mullerian aplasia (retarded uterus and vagina;to recruit larger, extended pedigrees. On the other hand,
like in most complex diseases, there are monogenic sub- Rdel137-161), were observed [20]. Hattersley et al identi-
fied two other HNF-1 families in 2001. These familiesforms for type 2, but not for type 1, diabetes. The at-risk
subjects come to clinical attention relatively early, as in had been diagnosed as having glomerulocystic kidney
disease before the detection of the mutations. AutosomalMaturity-Onset Diabetes of the Young (MODY). Sev-
eral affected individuals in each generation enable larger dominant polycystic kidney disease (ADPKD) was ex-
cluded. The cystic kidneys were hypoplastic. After inten-pedigrees that make it easier to perform genetic studies.
The idea of revealing the genetics of monogenic forms sified diagnostic screening, a mild, autosomal dominant
transmitted type 2 diabetes, which had not been seenconsists of an easy identification of genes which could
also explain the more common complex forms. This hope before, was detected [21].
Type 2 diabetes and renal failure can be expressed sohas not yet been fulfilled for type 2 diabetes. Neverthe-
less, it might be worth to describe one of the monogenic variably that other diagnoses such as type 1 diabetes and
forms to make it clear that nephropathy in diabetic pa- diabetic nephropathy come up. Renal failure can be de-
tients can occur as a nondiabetic nephropathy that has tected relatively early and at different progression steps
major implications for phenotyping in serious genetic (from a long history of proteinuria without hypertension,
studies. to ESRD and kidney transplantation). Sometimes an asso-
ciated Mullerian aplasia and hypoplastic kidneys with cysts
Monogenic, juvenile type 2 diabetes with nondiabetic can be observed. Typical signs of a diabetic nephropathy
renal failure (MODY5) are not evident in electron and light microscopy. It be-
comes obvious how carefully phenotyping must be car-MODY is a typical form of type 2 diabetes with an age
at onset before 25 years, and a clear autosomal dominant ried out in order to distinguish diabetic and nondiabetic
nephropathy.inheritance pattern with nearly 100% penetrance. Five
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Fig. 1. Position of the HNF-1 gene (MODY5)
within a transcription factor network.
Polygenic diabetes with diabetic nephropathy regions on chromosomes 7 and 20 were only linked with
nephropathy, and chromosomes 3 and 9 showed linkageClassic type 2 diabetes is a polygenic disease. It is very
with nephropathy and retinopathy. The sample size of 98likely that an interplay of specific allele constellations of
affected sib pairs in this study was also very small [22].various “diabetogenic” polymorphisms in different genes
Recently, linkage studies in concordant sib pairs,or regulatory elements makes the blood glucose regula-
which test only candidate genes/regions, but do not per-tion system more or less tolerant against environmental
form the entire genome scan, became more prevalent infactors such as overweight and stress. Those polymor-
literature. This is another possibility to test candidatephisms may occur at fairly high frequencies within the
genes by a robust linkage approach, followed up by asso-normal population. By looking at each one of them sepa-
ciation designs. This approach has not become successfulrately, the allele frequencies do not need to differ signifi-
so far. It has to be considered that this approach testscantly between cases and controls. One single polymor-
only a tiny part of the genome by using candidate genesphism can barely be responsible for the development of
exclusively. The biggest part of the genome remains com-type 2 diabetes.
pletely unrecognized. The phenotypic variation of a com-For classic type 2 diabetes, with and without diabetic
plex disease could be caused by a significant variationnephropathy, new genetic methods had to be developed
of gene regulation. Those regulatory sequences could bebecause of the lack of a clear inheritance model. Today,
located far away from the genes to be regulated. Thegenetic approaches, such as affected sib pairs and genetic
candidate gene approach would fail to detect the issue,analyses based on smaller (two- or even one-generation)
either by linkage or by association. Table 2 shows apedigrees, are preferentially used. The bottleneck is to
summary of some genome scans that have been carried
find concordant sib pairs with diabetes and diabetic ne-
out so far.
phropathy because of the very high mortality of this Further linkage studies in animal models and humans
particular group of patients. Therefore, many groups use identified chromosomal regions containing the so-called
other designs, such as discordant sib pairs. This approach renal failure genes (RF1, RF2). RF1 and RF2 predispose
is dangerous because no one can safely raise the affection for renal failure in an animal model characterized by
status. Who can know whether a subject who is presently hypertension and nephrosclerosis (fawn-hooded rat).
healthy will develop type 2 diabetes, and if so, will that The homologous region in the human genome on chro-
affected person progress to diabetic nephropathy? mosome 10 did not show linkage with the disease in Afri-
For the analysis of diabetic nephropathy there are only can Americans [23].
a few genetic linkage studies. The case numbers were
always too small; therefore, the size of the sample could
CONCLUSIONSnot be considered as representative. A genome scan in
affected type 2 diabetic sib pairs in Pima Indians with Diabetic nephropathy is a diabetic long-term compli-
cation that is responsible for the increased mortality ratediabetic nephropathy revealed four linked regions: the
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Table 2. Summary of linkage analyses and genome scans for unraveling the pathogenesis of diabetic nephropathy
Population Disease Design Candidate region/gene Positive loci
Caucasians [53] T2DM-DN xASP MODY1 (C20), MODY3 (C12) MODY1 (chromosome 20), MODY3 (chromosome 12)
Caucasians [54] T1DM-DN 66 DSP ACE, AGT, AT1 AT1, AT1 region (chromosome 20)
African Americans [55] T2DM-DN 85 ASP Renin angiotensin system —
Pima Indians [22] T2DM-DN 98 ASP Genome scan (516 markers) Chromosomes 7, 3, 9, 20
Italians [56] T2DM-DN 160 DSP ACE, AGT —
Abbreviations are: T1DM-DN, type 1 diabetes with diabetic nephropathy; T2DM-DN, type 2 diabetes with diabetic nephropathy; ASP, affected sib pairs; DSP,
discordant sib pairs; RP, relative pairs.
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